Press Release
Category Added in a WPeMatico Campaign
-
KVP International Strengthens Its Global Position with Rapid EU and Latin America Expansion
KVP accelerates growth with new EU distributor partnerships, Latin America distributor partnerships, expanded product categories, and the development of dedicated…
Read More » -
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics
Reqorsa® Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung Cancer AUSTIN, Texas, Oct. 14, 2025…
Read More » -
RTX’s Pratt & Whitney Canada signs APS5000 maintenance agreement with Lufthansa Airlines and Austrian Airlines
Agreement covers 41 APS5000 auxiliary power units on combined fleet of Boeing 787 Dreamliner aircraft LONDON, Oct. 14, 2025 /PRNewswire/ — Pratt…
Read More » -
Institutional Support for Shareholder Proposals Hits New Low, Broadridge ProxyPulse™ Report Finds
Institutional Shareholder Support for ESG at Its Lowest Level in Nine Years NEW YORK, Oct. 14, 2025 /PRNewswire/ — Institutional…
Read More » -
Top 10 NSFW AI Video Generators in 2025: Complete Guide
I’ve spent months exploring NSFW AI video generation platforms, and the landscape has completely transformed in 2025. New tools are…
Read More » -
Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection Co-Led by Acre Venture Partners and Corteva
Investment drives launch of Phytalix®, a new broad spectrum biofungicide delivering practical, sustainable disease control for farmers globally ITHACA, N.Y.–(BUSINESS…
Read More » -
Options Celebrates 10 Years of Award-Winning Graduate and Placement Programme
BELFAST, Northern Ireland & LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options Technology, the leading provider of infrastructure services to…
Read More » -
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced…
Read More »
